Pactiv Evergreen (NASDAQ:PTVE – Get Free Report)‘s stock had its “sector perform” rating reissued by stock analysts at Royal Bank of Canada in a research note issued on Thursday ...

On Tuesday, Citi issued a revision on Pactiv Evergreen's (NASDAQ:PTVE) stock, downgrading the rating from Buy to Neutral. This adjustment comes despite an increase in the price... Pactiv Evergreen ...

PTVE's execution on portfolio actions and continued cost benefits through the end of the year position the company well for future growth. A pivotal development for Pactiv Evergreen is its merger ...

CHARLOTTE, N.C. and LAKE FOREST, Ill., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Novolex ® and Pactiv Evergreen Inc. (NASDAQ: PTVE), announced today they have entered into a definitive agreement to ...

Jefferies downgraded Pactiv Evergreen (PTVE) to Hold from Buy with a price target of $18, up from $15. The firm cites the sale to Novolex for the downgrade and views the regulatory risk as manageable.

("Pactiv Evergreen" or "the Company") (NASDAQ:PTVE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Pactiv ...

9. Pactiv Evergreen will "combine" with Novolex, the Charlotte-based company that bought the company in an all-cash transaction valued at $6.7 billion, the Dec. 9 news release announced.

LOS ANGELES, CA / ACCESSWIRE / December 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Pactiv ...